Plus   Neg

Bed Bath & Beyond Shares Climb 7% On Analyst Upgrade

Shares of Bed Bath & Beyond Inc. (BBBY) are up 7% after an analyst at Wedbush upgraded the home goods retailer to outperform from neutral.

Wedbush's analyst Seth Basham, in a note to investors, wrote the Union, New Jersey-based company has a "good chance of stabilization" over the next two years as new changes take hold. He raised his stock price target to $16 from $14.

Basham also noted that with earnings report scheduled for Wednesday, the company might name a "well-regarded and highly experienced" CEO.

"While turning around declining retailers is a very difficult task, particularly amidst unfavorable secular trends and soft industry sales growth, we see a good chance of stabilization — if not growth — in earnings over the next two years as sweeping changes take hold," Basham wrote.

CEO Steven Temares had resigned as CEO and also from the board in May. The board had appointed Mary Winston as interim CEO.

The company also recently made several changes to transform itself, including reduction of its corporate staff by 7%, elimination of the role of the chief operating officer, and plans to cut inventory by about $1 billion.

BBBY is currently trading at $10.56, up $0.67 or 6.83%, on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NBCUniversal unveiled Peacock, a free premium ad-supported streaming service with subscription tiers offering more than 600 movies and 400 series. Peacock will be available on April 15 for Comcast's Xfinity X1 and Flex customers and on July 15 for the rest of the country. NBC is offering Peacock... The number of Amazon Prime members in the U.S. is growing slowly, but steadily, a recent study has shown. According to the survey by the Consumer Intelligence Research Partners, LLC or CIRP, the number of Amazon Prime members in the U.S. is estimated to have risen to 112 million in December 2019 from just over 100 million in the same period of the prior year. Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.
Follow RTT